Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease

Míreanna Comhchosúla

• Clinical and laboratory test in patients with familial amyloid polyneuropathy: differences between symptomatic patients and asymptomatic carriers
  le: Raya-Cruz, Manuel, et al.
  Foilsithe: (2015)
• Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study
  le: Reinés, Juan Buades, et al.
  Foilsithe: (2014)
• Transthyretin familial amyloid polyneuropathy (TTR‐FAP): Parameters for early diagnosis
  le: Escolano‐Lozano, Fabiola, et al.
  Foilsithe: (2017)
• Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP
  le: Parman, Yesim, et al.
  Foilsithe: (2016)
• Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area
  le: Mazzeo, Anna, et al.
  Foilsithe: (2015)